Advertisement
Editorial: Thank you for that question, Lester

Editorial: Thank you for that question, Lester

By Merrill Goozner  |  September 24, 2016

Last week, the New York Times posted an online poll asking its readers to choose which three of 15 possible questions they'd like to see the candidates address during the debates, which kick off Monday night. Only one touched on healthcare.

Editorial: The coming transformation

Editorial: The coming transformation

By Merrill Goozner  |  September 10, 2016

A key part of Modern Healthcare's mission is to help providers, payers and suppliers—our readers—with the news, information and data to succeed on higher-quality, lower-cost and more patient-centric care. That's why we are launching the Transformation Hub on our website.

Editorial: Time to act on mental health legislation

Editorial: Time to act on mental health legislation

By Merrill Goozner  |  September 03, 2016

No one has articulated a strategy for removing the estimated 350,000 mentally ill people incarcerated in the nation's jails and prisons. And no one is talking about how to fund a sharp increase in the number of long-term psychiatric beds in hospitals and other institutions. They clearly are needed.

Editorial: The unaffordable cost of M&A-driven drug prices

Editorial: The unaffordable cost of M&A-driven drug prices

By Merrill Goozner  |  August 27, 2016

There still is no connection between the price of new drugs and the cost of discovering and developing them, even though the pharmaceutical industry has argued for years that such a link was the primary justification for high prices.

Editorial: FLOTUS—the healthcare influential we forgot

Editorial: FLOTUS—the healthcare influential we forgot

By Merrill Goozner  |  August 20, 2016

Michelle Obama during her nearly eight years in the White House succeeded in changing the national conversation about diet and exercise, and gave a major boost to transparency about the foods we eat.

Editorial: Wage stagnation in healthcare

Editorial: Wage stagnation in healthcare

By Merrill Goozner  |  August 13, 2016

The harsh reality of modern-day America is that the less-educated, hourly workforce is falling further and further behind those still clinging to middle class status and above. This is a fairness issue that today characterizes almost every sector of the U.S. economy—including healthcare.

Editorial: Congress needs to stop dithering on Zika

Editorial: Congress needs to stop dithering on Zika

By Merrill Goozner  |  August 05, 2016

Don't hold your breath waiting for members of Congress to return to Washington to deal with the immediate public health threat posed by the Zika virus. That would require putting the public interest over politics, an approach gone missing in action during this poisonous election year.

Editorial: Full speed ahead on bundled payments

Editorial: Full speed ahead on bundled payments

By Merrill Goozner  |  July 30, 2016

Rulemakers in outgoing administrations usually end their tenures with a bang, not a whimper. President Barack Obama's appointees at the CMS are no exception.

Editorial: Don't shed tears for health insurers

Editorial: Don't shed tears for health insurers

By Merrill Goozner  |  July 23, 2016

A superficial reading of the latest headlines about the health insurance industry suggests it is facing serious problems, but the steady drumbeat of bad news for insurers is showing up everywhere except in the finances of the major carriers.

Editorial: Why assume healthcare cost controls will fail?

Editorial: Why assume healthcare cost controls will fail?

By Merrill Goozner  |  July 16, 2016

Last week, two well-respected groups of government economists predicted the end is nigh for the era of restrained growth in healthcare spending. Ignore them. They've been wrong before. They will be proven wrong again.

Editorial: Medicare Part B drug proposal deserves support

Editorial: Medicare Part B drug proposal deserves support

By Merrill Goozner  |  June 25, 2016

Medicare's first step in reining in the skyrocketing cost of specialty drugs deserves support—something it has not received from hospitals, doctors, politicians or, of course, the pharmaceutical industry, which benefits the most from the status quo.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.